Concert Pharmaceuticals has announced that it has entered into a strategic collaboration with Celgene directed towards deuterium-modified compounds targeting cancer and inflammation. The collaboration… more →
Silico Researchwrote 1 week ago: Concert Pharmaceuticals has announced that it has entered into a strategic collaboration with Celgen … more →
wrote 2 months ago: Jazz Pharmaceuticals and Concert Pharmaceuticals have announced an exclusive license agreement that … more →
wrote 9 months ago: Press Release FXT Series Edge filers improves ‘bursty’ VM traffic flow at Concert Pharmaceuticals PI … more →
wrote 1 year ago: Concert Pharmaceuticals and Fast Forward have announced that they have signed a collaboration to fun … more →
wrote 1 year ago: Avanir Pharmaceuticals and Concert Pharmaceuticals have announced that they have entered into an exc … more →
wrote 1 year ago: Concert Pharmaceuticals has announced that it has received a $4 million milestone payment from Glaxo … more →
wrote 3 years ago: Concert Pharmaceuticals and GlaxoSmithKline have entered an alliance to develop and commercialize de … more →